Title:
A Phase II, Randomized, Active controlled, Multi-Center study comparing efficacy and safety of targeted therapy or cander immunotherapy guided by genomic profiling versus platinum-based chemotherapy in patinets with CUP who have received three cycles of platinum doublet chemotherapy
Phase:
II
Contact:
Marie-Christin Vollmer / Study Nurse
Email-Address:
Marie-Christin.Vollmer@med.uni-heidelberg.de
Clinical Investigator:
Prof. Dr. Alwin Krämer
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT03498521
EudraCT-Number:
Siehe EU klinisches Studienregister
2017-003040-20